High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

AUTOR(ES)

Yanofsky, S D

RESUMO

Two families of peptides that specifically bind the extracellular domain of the human type I interleukin I (IL-1) receptor were identified from recombinant peptide display libraries. Peptides from one of these families blocked binding of IL-lalpha to the type I IL-1 receptor with IC50 values of 45-140 microM. Affinity-selective screening of variants of these peptides produced ligands of much higher affinity (IC50 approximately 2 nM). These peptides block IL-1-driven responses in human and monkey cells; they do not bind the human type II IL-1 receptor or the murine type I IL-1 receptor. This is the first example (that we know of) of a high affinity peptide that binds to a cytokine receptor and acts as a cytokine antagonist.

Documentos Relacionados

• Acetalins: opioid receptor antagonists determined through the use of synthetic peptide combinatorial libraries.
• High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.
• Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks
• High-affinity neuropeptide Y receptor antagonists.
• A PCR-based method for high stringency screening of DNA libraries.